Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine

NCT00310713 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Meningococcal Infection

Interventions

BIOLOGICAL: Meningococcal C conjugate vaccine

Sponsor

Novartis Vaccines